COVID-19 : U.S. impact on antimicrobial resistance, special report 2022
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates
...

to

...
Document Data
Library
People
Clear All
...
Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

COVID-19 : U.S. impact on antimicrobial resistance, special report 2022



Select the Download button to view the document
This document is over 5mb in size and cannot be previewed
English
Details Supporting Files You May Also Like

Details:

  • Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Division of Healthcare Quality Promotion.
  • Description:
    During the COVID-19 pandemic, the detection and reporting of antimicrobial resistance data slowed tremendously because of changes in patient care, lab supply challenges, testing, treatment, and the bandwidth of healthcare facilities and health departments.

    COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022, is a publication of the Antimicrobial Resistance Coordination and Strategy Unit within the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention.

    Suggested citation: CDC. COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2022. https://www.cdc.gov/drugresistance/covid19.html

    DOI:https://dx.doi.org/10.15620/cdc:117915

    covid19-impact-report-508.pdf

  • Content Notes:
    Foreword -- COVID-19 Impacts on Five Core Actions to Combat Antimicrobial Resistance Tracking and Data: Preventing Infections; Antibiotic Use; Environment (water, soil) and Sanitation; Vaccines, Diagnostics, and Therapeutics -- COVID-19 Impacts on 18 Antimicrobial-Resistant Bacteria and Fungi: Threat Estimates; Pathogen Summaries -- What’s Next: Building Public Health Capacity for Antimicrobial Resistance -- Technical Appendix: References; Data Methods.
  • Subjects:
  • Place as Subject:
    United States
  • Pages in Document:
    43 numbered pages
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:
    Filetype[PDF-10.66 MB]

Supporting Files

You May Also Like

Checkout today's featured content at stacks.cdc.gov